Cordycepin Decreases Ischemia/Reperfusion Injury in Diabetic Hearts via Upregulating AMPK/Mfn2-dependent Mitochondrial Fusion

• Egile Nagusiak: Houyou Yu (Egilea), Xin Hong (Egilea), Lihua Liu (Egilea), Yangpeng Wu (Egilea), Xuemei Xie (Egilea), Guoxiang Fang (Egilea), Shaomin Zhi (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2021-10-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Diabetes mellitus is considered to be a major risk factor for cardiovascular disease, the most common cause of death in diabetes. However, therapeutic strategies for myocardial protection in patients with diabetes are still limited. Cordycepin is a traditional Tibetan medicine with a long history of...